Publications by authors named "Sarah V Colonna"

Claim this Profile
T
Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.
Peh Joo Ho, Christine Kim Yan Loo, Ryan Jak Yang Lim, Meng Huang Goh, Mustapha Abubakar, Sarah V Colonna

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.
Daniel R Barnes, Jonathan P Tyrer, Joe Dennis, Goska Leslie, Manjeet K Bolla, Sarah V Colonna

NPJ Genom Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of Prior Patient Interactions With the Healthcare System to Engaging With Pretest Cancer Genetic Services via Digital Health Tools Among Unaffected Primary Care Patients: Findings From the BRIDGE Trial.
Lingzi Zhong, Jemar R Bather, Melody S Goodman, Lauren Kaiser-Jackson, Molly Volkmar, Sarah V Colonna

Health Serv Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries.
Peh Joo Ho, Christine Kim Yan Loo, Meng Huang Goh, Mustapha Abubakar, Thomas U Ahearn, Sarah V Colonna

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Summary and Roadmap of Breast Cancer Research in the Veterans Affairs.
Aditi Hazra, Karen M Goldstein, Susan E Waltz, Akiko Chiba, Sarah V Colonna

Mil Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical Activity during Adolescence and Early Adulthood and Breast Cancer Risk before Age 40 Years.
Rebecca D Kehm, Jeanine M Genkinger, Julia A Knight, Robert J MacInnis, Yuyan Liao, Sarah V Colonna

Cancer Epidemiol Biomarkers Prev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menopausal hormone therapy: assessing associations with breast and colorectal cancers by familial risk.
Robert J MacInnis, Mark A Jenkins, Roger L Milne, Esther M John, Mary B Daly, Sarah V Colonna

JNCI Cancer Spectr· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.
Kristia Yiangou, Nasim Mavaddat, Joe Dennis, Maria Zanti, Qin Wang, Sarah V Colonna

Breast Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models: The BRIDGE Randomized Clinical Trial.
Kimberly A Kaphingst, Wendy K Kohlmann, Rachelle Lorenz Chambers, Jemar R Bather, Melody S Goodman, Sarah V Colonna

JAMA Netw Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial Risk.
Jasmine A McDonald, Yuyan Liao, Julia A Knight, Esther M John, Allison W Kurian, Sarah V Colonna

JAMA Netw Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.
Daniel R Barnes, Jonathan P Tyrer, Joe Dennis, Goska Leslie, Manjeet K Bolla, Sarah V Colonna

medRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.
Kristia Yiangou, Nasim Mavaddat, Joe Dennis, Maria Zanti, Qin Wang, Sarah V Colonna

medRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Anna Morra, Maartje A C Schreurs, Irene L Andrulis, Hoda Anton-Culver, Annelie Augustinsson, Sarah V Colonna

Cancer Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
Karin Kast, Esther M John, John L Hopper, Nadine Andrieu, Catherine Noguès, Sarah V Colonna

Breast Cancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Anna Morra, Maartje A C Schreurs, Irene L Andrulis, Hoda Anton-Culver, Annelie Augustinsson, Sarah V Colonna

Res Sq· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry.
Stefanie H Mueller, Alvina G Lai, Maria Valkovskaya, Kyriaki Michailidou, Manjeet K Bolla, Sarah V Colonna

Genome Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Risks Associated With and Pathogenic Variants.
Shuai Li, Valentina Silvestri, Goska Leslie, Timothy R Rebbeck, Susan L Neuhausen, Sarah V Colonna

J Clin Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk.
Rebecca D Kehm, Robert J MacInnis, Esther M John, Yuyan Liao, Allison W Kurian, Sarah V Colonna

JNCI Cancer Spectr· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
Anna Morra, Maria Escala-Garcia, Jonathan Beesley, Renske Keeman, Sander Canisius, Sarah V Colonna

Breast Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial.
Kimberly A Kaphingst, Wendy Kohlmann, Rachelle Lorenz Chambers, Melody S Goodman, Richard Bradshaw, Sarah V Colonna

BMC Health Serv Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodies.
Kelsey Baron, Justin C Moser, Shiven Patel, Kenneth F Grossmann, Sarah V Colonna

J Oncol Pharm Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study.
Gordon P Watt, Janice Sung, Elizabeth A Morris, Saundra S Buys, Angela R Bradbury, Sarah V Colonna

Breast Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Valentina Silvestri, Goska Leslie, Daniel R Barnes, , Bjarni A Agnarsson, Sarah V Colonna

JAMA Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma.
Justin C Moser, Guo Wei, Sarah V Colonna, Kenneth F Grossmann, Shiven Patel

Acta Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab.
Justin C Moser, Danli Chen, Siwen Hu-Lieskovan, Kenneth F Grossmann, Shiven Patel, Sarah V Colonna

Cancer Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis